Status:
COMPLETED
Dose Response Study of a Fermented Yogurt on the Immune System and Gut Health
Lead Sponsor:
Laval University
Collaborating Sponsors:
Aliments ULTIMA Foods Inc.
McGill University
Conditions:
Immune System
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the dose-response effect of a yogurt containing a combination of bifidobacterium Lactis (BB-12) and Lactobacillus Acidophilus (LA-5) and green tea extract on ...
Detailed Description
There is an increasing list of food containing probiotics on the market. Several studies have emphasized the health benefits of single probiotics, particularly on the immune system. However, it is unc...
Eligibility Criteria
Inclusion
- Age between 18 to 55 years
- Healthy individuals, non-smokers
- BMI between 18 and 35 kg/m2
- Stable weight (+/- 5kg) for 3 months before randomisation
- Agree to receive a vaccine Pneumovax 23®
Exclusion
- Pregnant or lactating woman
- Previous history of cardiovascular disease
- Diabetes
- Kidney or liver disease
- Gastrointestinal disorders or diseases
- Endocrine disorders or diseases
- Allergy
- Subjects taking hypolipidemic drugs, antidepressant, medication for high blood pressure, for inflammation or auto-immune diseases.
- Subject who have receive antipneumococcics vaccine in the year before randomisation.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00730626
Start Date
August 1 2008
End Date
May 1 2009
Last Update
June 22 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Nutraceuticals and Functional Foods (INAF), Laval University
Québec, Quebec, Canada, G1V 0A6